238 related articles for article (PubMed ID: 23459488)
1. Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.
Lau CH; Fraud S; Jones M; Peterson SN; Poole K
Antimicrob Agents Chemother; 2013 May; 57(5):2243-51. PubMed ID: 23459488
[TBL] [Abstract][Full Text] [Related]
2. AmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.
Lau CH; Krahn T; Gilmour C; Mullen E; Poole K
Microbiologyopen; 2015 Feb; 4(1):121-35. PubMed ID: 25450797
[TBL] [Abstract][Full Text] [Related]
3. The aminoglycoside resistance-promoting AmgRS envelope stress-responsive two-component system in Pseudomonas aeruginosa is zinc-activated and protects cells from zinc-promoted membrane damage.
Poole K; Hay T; Gilmour C; Fruci M
Microbiology (Reading); 2019 May; 165(5):563-571. PubMed ID: 30835196
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional and Mutational Profiling of an Aminoglycoside-Resistant Pseudomonas aeruginosa Small-Colony Variant.
Schniederjans M; Koska M; Häussler S
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874369
[No Abstract] [Full Text] [Related]
5. Potentiation of Aminoglycoside Activity in Pseudomonas aeruginosa by Targeting the AmgRS Envelope Stress-Responsive Two-Component System.
Poole K; Gilmour C; Farha MA; Mullen E; Lau CH; Brown ED
Antimicrob Agents Chemother; 2016 Jun; 60(6):3509-18. PubMed ID: 27021319
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant mutants of pseudomonas aeruginosa.
Lau CH; Fraud S; Jones M; Peterson SN; Poole K
Antimicrob Agents Chemother; 2012 Oct; 56(10):5171-9. PubMed ID: 22825121
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system.
Fruci M; Poole K
PLoS One; 2018; 13(10):e0205036. PubMed ID: 30289929
[TBL] [Abstract][Full Text] [Related]
8. Role of the MexXY multidrug efflux pump in moderate aminoglycoside resistance in Pseudomonas aeruginosa isolates from Pseudomonas mastitis.
Chuanchuen R; Wannaprasat W; Ajariyakhajorn K; Schweizer HP
Microbiol Immunol; 2008 Aug; 52(8):392-8. PubMed ID: 18667038
[TBL] [Abstract][Full Text] [Related]
9. Targeting a bacterial stress response to enhance antibiotic action.
Lee S; Hinz A; Bauerle E; Angermeyer A; Juhaszova K; Kaneko Y; Singh PK; Manoil C
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14570-5. PubMed ID: 19706543
[TBL] [Abstract][Full Text] [Related]
10. Aminoglycoside resistance mechanisms in Pseudomonas aeruginosa isolates from non-cystic fibrosis patients in Thailand.
Poonsuk K; Tribuddharat C; Chuanchuen R
Can J Microbiol; 2013 Jan; 59(1):51-6. PubMed ID: 23391230
[TBL] [Abstract][Full Text] [Related]
11. Mutations in Gene
Bolard A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
[TBL] [Abstract][Full Text] [Related]
12. MexY-promoted aminoglycoside resistance in Pseudomonas aeruginosa: involvement of a putative proximal binding pocket in aminoglycoside recognition.
Lau CH; Hughes D; Poole K
mBio; 2014 Apr; 5(2):e01068. PubMed ID: 24757215
[TBL] [Abstract][Full Text] [Related]
13. Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.
Krahn T; Gilmour C; Tilak J; Fraud S; Kerr N; Lau CH; Poole K
Antimicrob Agents Chemother; 2012 Nov; 56(11):5591-602. PubMed ID: 22908149
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.
Sobel ML; McKay GA; Poole K
Antimicrob Agents Chemother; 2003 Oct; 47(10):3202-7. PubMed ID: 14506031
[TBL] [Abstract][Full Text] [Related]
15. Rifampicin potentiation of aminoglycoside activity against cystic fibrosis isolates of Pseudomonas aeruginosa.
Mikalauskas A; Parkins MD; Poole K
J Antimicrob Chemother; 2017 Dec; 72(12):3349-3352. PubMed ID: 28961705
[TBL] [Abstract][Full Text] [Related]
16. Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of
Ahmadian L; Norouzi Bazgir Z; Ahanjan M; Valadan R; Goli HR
Biomed Res Int; 2021; 2021():7077344. PubMed ID: 34471641
[TBL] [Abstract][Full Text] [Related]
17. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
Gutu AD; Sgambati N; Strasbourger P; Brannon MK; Jacobs MA; Haugen E; Kaul RK; Johansen HK; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2013 May; 57(5):2204-15. PubMed ID: 23459479
[TBL] [Abstract][Full Text] [Related]
18. Membrane proteases and aminoglycoside antibiotic resistance.
Hinz A; Lee S; Jacoby K; Manoil C
J Bacteriol; 2011 Sep; 193(18):4790-7. PubMed ID: 21764915
[TBL] [Abstract][Full Text] [Related]
19. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.
Singh M; Yau YCW; Wang S; Waters V; Kumar A
Can J Microbiol; 2017 Dec; 63(12):929-938. PubMed ID: 28922614
[TBL] [Abstract][Full Text] [Related]
20. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
